Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT02535364 · TERMINATED
Trial details
- NCT number
- NCT02535364
- Sponsor
- Juno Therapeutics, a Subsidiary of Celgene
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-21
- Primary completion
- 2017-04-24
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.